Toxic Advanced Glycation End-Products-Dependent Alzheimer's Disease- Like Alternation in the Microtubule System

Curr Alzheimer Res. 2023;20(10):677-681. doi: 10.2174/0115672050288723240213053342.

Abstract

Type 2 diabetes mellitus (T2DM) is a risk factor for Alzheimer's Disease (AD). However, the detailed mechanism underlying T2DM-related AD remains unknown. In DM, many types of advanced glycation end-products (AGEs) are formed and accumulated. In our previous study, we demonstrated that Glyceraldehyde (GA)-derived Toxic Advanced Glycation End-products (Toxic AGEs, TAGE) strongly showed cytotoxicity against neurons and induced similar alterations to those observed in AD. Further, GA induced dysfunctional neurite outgrowth via TAGE-β-- tubulin aggregation, which resulted in the TAGE-dependent abnormal aggregation of β-tubulin and tau phosphorylation. Herein, we provide a perspective on the possibility that T2DM increases the probability of AD onset and accelerates its progression.

Keywords: Alzheimer’s disease; Toxic advanced glycation end-products; diabetes mellitus; glyceraldehyde; tau phosphorylation.; β-tubulin.

MeSH terms

  • Alzheimer Disease* / etiology
  • Diabetes Mellitus, Type 2* / complications
  • Glycation End Products, Advanced / toxicity
  • Glyceraldehyde
  • Humans
  • Maillard Reaction
  • Microtubules

Substances

  • Glycation End Products, Advanced
  • Glyceraldehyde